Evogene (NASDAQ:EVGN) Now Covered by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Evogene (NASDAQ:EVGN) in a research report sent to investors on Sunday. The brokerage issued a sell rating on the biotechnology company’s stock.

Evogene Price Performance

EVGN opened at $0.82 on Friday. The business has a 50 day simple moving average of $0.72 and a two-hundred day simple moving average of $0.77. The firm has a market capitalization of $33.80 million, a price-to-earnings ratio of -1.78 and a beta of 1.47. Evogene has a one year low of $0.45 and a one year high of $1.44.

Evogene (NASDAQ:EVGN) last released its quarterly earnings results on Thursday, March 7th. The biotechnology company reported ($0.13) EPS for the quarter, beating analysts’ consensus estimates of ($0.14) by $0.01. The business had revenue of $0.58 million during the quarter, compared to analyst estimates of $1.73 million. Evogene had a negative return on equity of 67.34% and a negative net margin of 233.66%. During the same quarter in the prior year, the company posted ($0.07) EPS.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Evogene stock. BNP Paribas Financial Markets raised its holdings in shares of Evogene Ltd. (NASDAQ:EVGN) by 30.8% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 91,400 shares of the biotechnology company’s stock after purchasing an additional 21,500 shares during the period. BNP Paribas Financial Markets owned 0.22% of Evogene worth $69,000 at the end of the most recent reporting period. 10.40% of the stock is owned by hedge funds and other institutional investors.

About Evogene

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications.